Note: This section contains information in English only.Moderna and Merck's mRNA shot met late-stage trial goals by cutting skin cancer recurrence and spread, sending Moderna shares up.
Wed, 19 Aug 2026 18:30:04 GMT
Source: Dukascopy Bank SA